Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02146794
Eligibility Criteria:
Inclusion Criteria:
-Patients were required to have chronic symptomatic systolic heart failure (NYHA class III or IV) on maximal tolerated medical therapy, including beta-blocker, ACE inhibitor or angiotensin receptor blocker, and spironolactone.
Exclusion Criteria:
* Clinically unstable patients or those with significant valvular disease
* An estimated glomerular filtration rate \<35 ml/min
* Unfavourable renal anatomy
* Tortuous femoral arteries were not eligible
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02146794
Study Brief:
Protocol Section:
NCT02146794